Metraipolis › archive › dc_bc2ac6346902
Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world… — Europe PMC PMID:41646844
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41646844
- DOI
- 10.3389/fimmu.2026.1731123
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T15:21:54.510Z
- SHA-256 of the archived text
31bb269d0744af863cb195676f19f2687ef9982d3a190da6710ba5b707048f54- Stable URL of this page
https://metraipolis.com/documento/dc_bc2ac6346902
How to cite
Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world… — Europe PMC PMID:41646844 — Europe PMC (en), https://europepmc.org/article/MED/41646844 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc2ac6346902 (Metraipolis archive dc_bc2ac6346902, sha256 31bb269d0744af863cb195676f19f2687ef9982d3a190da6710ba5b707048f54)
BibTeX
@misc{dcbc2ac6346902,
title = {Clinical impact of first-line chemotherapy combined with immune checkpoint inhibitors for limited-stage small cell lung cancer patients: a real-world… — Europe PMC PMID:41646844},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41646844},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc2ac6346902; sha256 31bb269d0744af863cb195676f19f2687ef9982d3a190da6710ba5b707048f54},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646844. Agents can read the archived copy with the MCP tool read_document.